MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,548,223 | -50.3% | 51,686 | -21.4% | 0.04% | -48.7% |
| Q2 2023 | $15,190,791 | -8.7% | 65,761 | -4.2% | 0.08% | -15.6% |
| Q1 2023 | $16,634,541 | -5.1% | 68,664 | +13.7% | 0.09% | -10.9% |
| Q4 2022 | $17,533,132 | +979.6% | 60,407 | +141.7% | 0.10% | +818.2% |
| Q3 2022 | $1,624,000 | +237.6% | 24,989 | +271.6% | 0.01% | +266.7% |
| Q2 2022 | $481,000 | +46.2% | 6,725 | +100.8% | 0.00% | +50.0% |
| Q1 2022 | $329,000 | -12.7% | 3,349 | -24.7% | 0.00% | 0.0% |
| Q4 2021 | $377,000 | +83.9% | 4,445 | +72.7% | 0.00% | +100.0% |
| Q3 2021 | $205,000 | -72.7% | 2,574 | -61.3% | 0.00% | -80.0% |
| Q4 2018 | $750,000 | -58.5% | 6,650 | -21.3% | 0.01% | -50.0% |
| Q3 2018 | $1,809,000 | – | 8,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |